TRCT
ACH

Tower Research Capital (TRC)’s Accendra Health ACH Stock Holding History

Tower Research Capital (TRC)’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Buy
7,720
+891
+13% +$2.77K ﹤0.01% 3314
2026
Q1 		$15.6K Sell
6,829
-1,300
-16% -$2.99K ﹤0.01% 3661
2025
Q4 		$22.8K Sell
8,129
-3,598
-31% -$12.9K ﹤0.01% 3001
2025
Q3 		$56.3K Buy
11,727
+4,179
+55% +$26.6K ﹤0.01% 2439
2025
Q2 		$68.7K Buy
7,548
+5,567
+281% +$41K ﹤0.01% 2704
2025
Q1 		$17.9K Sell
1,981
-18,278
-90% -$193K ﹤0.01% 3080
2024
Q4 		$265K Buy
20,259
+2,112
+12% +$28.2K 0.01% 1517
2024
Q3 		$285K Buy
18,147
+6,873
+61% +$104K 0.01% 1299
2024
Q2 		$152K Buy
11,274
+8,352
+286% +$171K ﹤0.01% 2277
2024
Q1 		$81K Sell
2,922
-22,063
-88% -$490K ﹤0.01% 1954
2023
Q4 		$481K Buy
24,985
+23,327
+1,407% +$422K 0.01% 1389
2023
Q3 		$26.8K Sell
1,658
-134
-7% -$2.38K ﹤0.01% 3116
2023
Q2 		$34.1K Sell
1,792
-2,666
-60% -$47.5K ﹤0.01% 2906
2023
Q1 		$65K Sell
4,458
-5,273
-54% -$94.4K ﹤0.01% 2269
2022
Q4 		$190K Sell
9,731
-9,495
-49% -$185K 0.01% 1338
2022
Q3 		$463K Sell
19,226
-1,297
-6% -$40K 0.01% 1208
2022
Q2 		$646K Buy
20,523
+20,176
+5,814% +$731K 0.01% 969
2022
Q1 		$15K Sell
347
-15,585
-98% -$669K ﹤0.01% 3828
2021
Q4 		$693K Sell
15,932
-18,051
-53% -$708K 0.01% 905
2021
Q3 		$1.06M Buy
33,983
+16,505
+94% +$650K 0.03% 503
2021
Q2 		$740K Sell
17,478
-2,817
-14% -$110K 0.02% 877
2021
Q1 		$763K Buy
20,295
+13,061
+181% +$408K 0.01% 920
2020
Q4 		$196K Sell
7,234
-54,549
-88% -$1.4M 0.01% 1722
2020
Q3 		$1.55M Buy
61,783
+42,740
+224% +$623K 0.02% 583
2020
Q2 		$145K Buy
19,043
+16,843
+766% +$123K 0.01% 2113
2020
Q1 		$20K Buy
2,200
+340
+18% +$2.05K ﹤0.01% 1715
2019
Q4 		$10K Sell
1,860
-1,760
-49% -$11.3K ﹤0.01% 2337
2019
Q3 		$21K Buy
3,620
+100
+3% +$448 ﹤0.01% 2443
2019
Q2 		$11K Buy
3,520
+3,330
+1,753% +$11.4K ﹤0.01% 2506
2019
Q1 		$1K Buy
190
+36
+23% +$228 ﹤0.01% 3595
2018
Q4 		$1K Sell
154
-5,782
-97% -$60K ﹤0.01% 3635
2018
Q3 		$98K Buy
5,936
+4,181
+238% +$71.1K 0.01% 1363
2018
Q2 		$29K Buy
1,755
+91
+5% +$1.47K ﹤0.01% 2194
2018
Q1 		$26K Buy
1,664
+1,258
+310% +$22.4K ﹤0.01% 2037
2017
Q4 		$8K Sell
406
-5,757
-93% -$128K ﹤0.01% 2672
2017
Q3 		$180K Buy
6,163
+5,963
+2,982% +$176K 0.01% 844
2017
Q2 		$6K Buy
200
+100
+100% +$3.28K ﹤0.01% 1905
2017
Q1 		$3K Sell
100
-2,913
-97% -$104K ﹤0.01% 2482
2016
Q4 		$106K Sell
3,013
-3,149
-51% -$106K 0.01% 937
2016
Q3 		$214K Sell
6,162
-197
-3% -$6.9K 0.02% 448
2016
Q2 		$237K Buy
6,359
+5,139
+421% +$193K 0.02% 564
2016
Q1 		$49K Buy
1,220
+1,180
+2,950% +$43.9K 0.01% 787
2015
Q4 		$1K Sell
40
-1,915
-98% -$69.3K ﹤0.01% 4128
2015
Q3 		$62K Sell
1,955
-250
-11% -$8.51K 0.01% 871
2015
Q2 		$75K Sell
2,205
-1,921
-47% -$64.7K 0.01% 1064
2015
Q1 		$140K Buy
+4,126
New +$144K 0.02% 627
2014
Q4 		– Sell
-3,782
Closed -$127K – 4501
2014
Q3 		$124K Sell
3,782
-4,124
-52% -$140K 0.01% 761
2014
Q2 		$268K Buy
7,906
+7,594
+2,434% +$260K 0.03% 482
2014
Q1 		$11K Buy
312
+28
+10% +$988 ﹤0.01% 2513
2013
Q4 		$10K Sell
284
-6,925
-96% -$254K ﹤0.01% 2991
2013
Q3 		$249K Buy
7,209
+6,809
+1,702% +$238K 0.03% 625
2013
Q2 		$14K Buy
+400
New +$13.3K ﹤0.01% 2052

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Tower Research Capital (TRC)'s ACH Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Accendra Health (ACH) stake by 13% in Q2 2026, buying an estimated $2.77K and bringing the position to 7,720 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3314.

Tower Research Capital (TRC) first reported a position in ACH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.55M in Q3 2020. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Tower Research Capital (TRC) held 7,720 shares of Accendra Health worth $26.4K as of Q2 2026.
  • Tower Research Capital (TRC) bought 891 Accendra Health shares in Q2 2026, an estimated $2.77K.
  • Accendra Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3314 holding.
  • Tower Research Capital (TRC) first reported a position in Accendra Health in Q2 2013 and has held it in 52 quarters since.
  • Tower Research Capital (TRC)'s Accendra Health position peaked at $1.55M in Q3 2020.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.